Antimicrobial susceptibility of urinary Klebsiella pneumoniae and the emergence of carbapenem-resistant strains: A retrospective study from a university hospital in Morocco, North Africa

African Journal of Urology

Volumn 21, Issue 1, 2015, Pages 36-40

  El Bouamri, M C ^a,b   Arsalane, L ^a,c   El Kamouni, Y ^a,c   Zouhair, S ^a,b  

^a The Microbiology Laboratory of the Avicenne Military Teaching Hospital of Marrakech   (Morocco)

^b MOHAMMED V UNIVERSITY   (Morocco)

^c CADI AYYAD UNIVERSITY   (Morocco)

Author keywords

Antimicrobial resistance; Klebsiella pneumoniae; Urinary

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CONTROLLED STUDY; HOSPITAL PATIENT; HUMAN; KLEBSIELLA PNEUMONIAE; MOROCCO; NONHUMAN; OUTPATIENT; RETROSPECTIVE STUDY; UNIVERSITY HOSPITAL; URINALYSIS;

EID: 84928204447     PISSN: 11105704     EISSN: 19619987     Source Type: Journal    
DOI: 10.1016/j.afju.2014.10.004     Document Type: Article

References (30)

1. Daza R., Gutierrez J., Piedrola G. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections. Int J Antimicrob Agents 2001, 18:211-215.
2. Schito G.C., Naber K.G., Botto H., Palou J., Mazzei T., Gualco L., et al. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Int J Antimicrob Agents 2009, 34:407-413.
3. Pitout J.D., Sanders C.C., Sanders W.E. Antimicrobial resistance with focus on beta-lactam resistance in Gram negative bacilli. Am J Med 1997, 103:51-59.
4. Perez F., Endimiani A., Hujer K.M., Bonomo R.A. The continuing challenge of ESBLs. Curr Opin Pharmacol 2007, 7:459-469.
5. Bader M.S., Hawboldt J., Brooks A. Management of complicated urinary tract infections in the era of antimicrobial resistance. Postgrad Med 2010, 122:7-15.
6. http://www.sfm-microbiologie.org/.
7. Hooton T.M. Pathogenesis of urinary tract infection: an update. J Antimicrob Chemother 2000, 46:S1-S7.
8. Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. J Antimicrob Chemother 2003, 51(1):69-76.
9. Deshpande L.M., Fritsche T.R., Jones R.N. Molecular epidemiology of selected multi-drug resistant bacteria: a global report from the SENTRY Antimicrobial Surveillance Program. Diagn Microbiol Infect Dis 2004, 49:231-236.
10. Tenssaie Z.W. Multiple antimicrobial resistance in gram negative bacilli isolated from clinical specimens, Jimma Hospital, southwest Ethiopia. Ethiop Med J 2001, 39:305-312.
11. Pieboji J.G., Koulla-Shiro S., Ngassam P., Adiogo D., Njine T., Ndumbe P. Antimicrobial resistance of Gram-negative bacilli isolates from inpatients and outpatients at Yaounde Central Hospital, Cameroon. Int J Infect Dis 2004, 8:147-154.
12. Lahlou A., Chegri M., L'Kassmi H. Épidémiologie et résistance aux antibiotiques des entérobactéries isolées d'infections urinaires à l'hÔpital militaire Moulay-Ismail de Meknès. Antibiotiques 2009, 11:90-96.
13. Tlamcani Z., Ellaia K., Benomar A., Kabbaj H., Alaoui A.E., Seffar M. La résistance aux fluoroquinolones chez des souches de Klebsiella spp. productrices de betalactamase à spectre étendu isolées dans les urines. Ann Biol Clin 2009, 67:553-556.
14. Tenover F.C. Mechanisms of antimicrobial resistance in bacteria. Am J Med 2006, 119(6 Suppl. 1):S3-S10. discussion S62-70.
15. Wise R., Andrews J.M. Local surveillance of antimicrobial resistance. Lancet 1998, 22(352):657-658.
16. Livermore D.M. β-lactamases in laboratory and clinical resistance. Clin Microbiol 1995, 8:557-584.
17. Bouzenoune F., Boudersa F., Bensaad A., Harkat F., Siad N. Les infections urinaires à Ain M'lila (Algérie). Résistance aux antibiotiques des 239 souches isolées entre 2006 et 2007. Med Mal 2009, 39:142-143.
18. Ben Haj Khalifa A., Khedher M. Epidémiologie des souches de Klebsiella spp. uropathogènes productrices de b-lactamases à spectre élargi dans un hÔpital universitaire Tunisien, 2009. Pathol Biol 2012, 60:e1-e5.
19. Nordmann P., Mammeri H. Résistance plasmidique aux quinolones. Antibiotiques 2007, 9:246-253.
20. Knothe H., Shah P., Krcmery V., Antal M., Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 1983, 11:315-317.
21. Jones R.N. Global epidemiology of antimicrobial resistance among community-acquired and nosocomial pathogens: a five-year summary from the SENTRY antimicrobial surveillance program (1997-2001). Semin Respir Crit Care Med 2003, 24:21-34.
22. El Bouamri M.C., Arsalane L., Kamouni Y., Berraha M., Zouhair S. Évolution récente du profil épidémiologique des entérobactéries uropathogènes productrices de B-lactamases à spectre élargi à Marrakech. Maroc. Prog Urol 2014, 24:451-455.
23. Belmonte O., Drouet D., Alba J., Moiton M.P., Kuli B., Lugagne-Delpon N., et al. Evolution de la résistance des entérobactéries aux antibiotiques sur l'ile de la Réunion: émergence des beta-lactamases à spectre élargi. Path Biol 2010, 58:18-24.
24. Romero E.D.V., Padilla T.P., Hernandez A.H., Grande R.P., Vazquez M.F., Garcia I.G., et al. Prevalence of clinical isolates of Escherichia coli and Klebsiella spp. producing multiple extended-spectrum β-lactamases. Diagn Microbiol Infect Dis 2007, 59:433-437.
25. Bush K. New β-lactamases in Gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy. Clin Infect Dis 2001, 32:1085-1089.
26. Barguigua A., El Otmani F., Talmi M., Bourjilat F., Haouzane F., Zerouali K., et al. Characterization of ESBL-producing Escherichia coli and Klebsiella pneumoniae isolates from community in Morocco. J Med Microbiol 2011, 60:1344-1352.
27. Canton R., Coque T.M. The CTX-M β-lactamase pandemic. Curr Opin Microbiol 2006, 9:466-475.
28. Paterson D.L., Ko W.C., Von Gottberg A., Casellas J.M., Mulazimoglu L., Klugman K.P., et al. Outcome of cephalosporin treatment for serious infections due to apparently susceptible organisms producing extended-spectrum beta-lactamases: implications for the clinical microbiology laboratory. J Clin Microbiol 2001, 39:2206-2212.
29. Colodner R., Raz R., Chazan B., Sakran W. Susceptibility pattern of ESBL-producing bacteria isolated from inpatients to five antimicrobial drugs in a community hospital in northern Israel. Int J Antimicrob Agents 2004, 24:409-410.
30. Benouda A., Touzani O., Khairallah M.T., Araj G.F., Matar G.M. First detection of oxacillinase-mediated resistance to carbapenems in Klebsiella pneumoniae from Morocco. Ann Trop Med Parasitol 2010, 104:327-330.